Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Meir Schechter

9PUBLICATIONS

15CO-AUTHORS

PharmacogenomicsAutonomic nervous systemMajor global burdens of diseaseEpidemiological modellingGene expression (incl. microarray and other genome-wide approaches)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 23, 2025

Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists Versus Other Glucose-Lowering Agents in People With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Data.

Alisa Fishkin, Aliza Rozenberg, Meir Schechter

|Jul 18, 2024

Normoalbuminuria-is it normal? The association of urinary albumin within the 'normoalbuminuric' range with adverse cardiovascular and mortality outcomes: A systematic review and meta-analysis.

Dvora R Sehtman-Shachar, Ilan Yanuv, Meir Schechter

|Jul 17, 2023

Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease.

Meir Schechter, Glenn M Chertow, Hiddo J L Heerspink

|Jun 29, 2023

Risk of hospitalization with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real-world data.

Meir Schechter, Cheli Melzer Cohen, Tamir Zelter

|Jun 29, 2023

Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease.

Cheli Melzer Cohen, Meir Schechter, Aliza Rozenberg

|Dec 05, 2022

Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD.

Meir Schechter, Niels Jongs, Glenn M Chertow

Pageof 2

Frequent Collaborators

4 joint publications

Ofri Mosenzon

2 joint publications

Glenn M Chertow

2 joint publications

Dvora R Sehtman-Shachar

2 joint publications

Hiddo J L Heerspink

2 joint publications

Cheli Melzer Cohen

1 joint publications

Faina Tsodikov

1 joint publications

Yuri Gimelfarb

1 joint publications

John J V McMurray

1 joint publications

Peter Rossing

1 joint publications

Anna Maria Langkilde

Frequent Collaborators

4 joint publications

Ofri Mosenzon

2 joint publications

Glenn M Chertow

2 joint publications

Dvora R Sehtman-Shachar

2 joint publications

Hiddo J L Heerspink

Top Related Videos

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on : Nov 16, 2011

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on : Jun 16, 2014

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on : May 26, 2022

See more related videos

Top Related Videos

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on : Nov 16, 2011

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on : Jun 16, 2014

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on : May 26, 2022

See more related videos